LAUSR

Pretomanid: First Approval

Sign Up to like & get
recommendations!
0 Published in 2019 at "Drugs"

DOI: 10.1007/s40265-019-01207-9

Abstract: Pretomanid, an oral nitroimidazooxazine antimycobacterial agent administered as part of the BPaL (bedaquiline, pretomanid and linezolid) and BPaMZ (bedaquiline, pretomanid, moxifloxacin and pyrazinamide) regimens, has been developed by the Global Alliance for TB Drug Development… read more here.

Keywords: part; pretomanid; first approval; alliance ... See more keywords